EP
Eversept Partners’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,644,988
| Closed | -$11.2M | – | 57 |
|
|
2023
Q3 | $11.2M | Sell |
2,644,988
-2,620,263
| -50% | -$11.1M | 0.94% | 21 |
|
|
2023
Q2 | $16.3M | Buy |
5,265,251
+82,205
| +2% | +$255K | 1.36% | 17 |
|
|
2023
Q1 | $7.2M | Buy |
5,183,046
+4,352,086
| +524% | +$6.05M | 0.5% | 34 |
|
|
2022
Q4 | $1.65M | Sell |
830,960
-3,859,852
| -82% | -$7.68M | 0.14% | 47 |
|
|
2022
Q3 | $9.48M | Sell |
4,690,812
-803,468
| -15% | -$1.62M | 0.82% | 23 |
|
|
2022
Q2 | $17.5M | Buy |
5,494,280
+2,783
| +0.1% | +$8.85K | 1.24% | 20 |
|
|
2022
Q1 | $22.9M | Sell |
5,491,497
-949,075
| -15% | -$3.96M | 1.76% | 16 |
|
|
2021
Q4 | $30.9M | Sell |
6,440,572
-409,262
| -6% | -$1.96M | 1.97% | 13 |
|
|
2021
Q3 | $36.6M | Buy |
6,849,834
+1,225,109
| +22% | +$6.54M | 2.53% | 11 |
|
|
2021
Q2 | $28.8M | Buy |
5,624,725
+869,245
| +18% | +$4.45M | 1.92% | 16 |
|
|
2021
Q1 | $32M | Buy |
4,755,480
+3,577,327
| +304% | +$24.1M | 2.41% | 13 |
|
|
2020
Q4 | $5.38M | Sell |
1,178,153
-1,478,055
| -56% | -$6.75M | 0.63% | 32 |
|
|
2020
Q3 | $10.3M | Buy |
2,656,208
+1,769,621
| +200% | +$6.87M | 2.29% | 15 |
|
|
2020
Q2 | $4.22M | Buy |
+886,587
| New | +$4.22M | 0.58% | 28 |
|